Literature DB >> 16792677

Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?

D M Vitelli-Avelar1, R Sathler-Avelar, R L Massara, J D Borges, P S Lage, M Lana, A Teixeira-Carvalho, J C P Dias, S M Elói-Santos, O A Martins-Filho.   

Abstract

The immunological response during early human Trypanosoma cruzi infection is not completely understood, despite its role in driving the development of distinct clinical manifestations of chronic infection. Herein we report the results of a descriptive flow cytometric immunophenotyping investigation of major and minor peripheral blood leucocyte subpopulations in T. cruzi-infected children, characterizing the early stages of the indeterminate clinical form of Chagas' disease. Our results indicated significant alterations by comparison with uninfected children, including increased values of pre-natural killer (NK)-cells (CD3- CD16+ CD56-), and higher values of proinflammatory monocytes (CD14+ CD16+ HLA-DR++). The higher values of activated B lymphocytes (CD19+ CD23+) contrasted with impaired T cell activation, indicated by lower values of CD4+ CD38+ and CD4+ HLA-DR+ lymphocytes, a lower frequency of CD8+ CD38+ and CD8+ HLA-DR+ cells; a decreased frequency of CD4+ CD25HIGH regulatory T cells was also observed. These findings reinforce the hypothesis that simultaneous activation of innate and adaptive immunity mechanisms in addition to suppression of adaptive cellular immune response occur during early events of Chagas' disease. Comparative cross-sectional analysis of these immunophenotypes with those exhibited by patients with late chronic indeterminate and cardiac forms of disease suggested that a shift toward high values of macrophage-like cells extended to basal levels of proinflammatory monocytes as well as high values of mature NK cells, NKT and regulatory T cells, may account for limited tissue damage during chronic infection favouring the establishment/maintenance of a lifelong indeterminate clinical form of the disease. On the other hand, development of an adaptive cell-mediated inflammatory immunoprofile characterized by high levels of activated CD8+ cells and basal levels of mature NK cells, NKT and CD4+ CD25HIGH cells might lead to late chronic pathologies associated with chagasic heart disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792677      PMCID: PMC1942003          DOI: 10.1111/j.1365-2249.2006.03123.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation.

Authors:  H W Ziegler-Heitbrock
Journal:  Immunol Today       Date:  1996-09

2.  Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.

Authors:  D M Vitelli-Avelar; R Sathler-Avelar; J C P Dias; V P M Pascoal; A Teixeira-Carvalho; P S Lage; S M Elói-Santos; R Corrêa-Oliveira; O A Martins-Filho
Journal:  Scand J Immunol       Date:  2005-09       Impact factor: 3.487

Review 3.  The importance of aberrant T-cell responses in Chagas disease.

Authors:  George A DosReis; Celio G Freire-de-Lima; Marise P Nunes; Marcela F Lopes
Journal:  Trends Parasitol       Date:  2005-05

4.  Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.

Authors:  J C Aliberti; M A Cardoso; G A Martins; R T Gazzinelli; L Q Vieira; J S Silva
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro.

Authors:  C A Bento; M B Melo; J O Previato; L Mendonça-Previato; L M Peçanha
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

6.  Multiple sites of post-activation CD8+ T cell disposal.

Authors:  A Wack; P Corbella; N Harker; I N Crispe; D Kioussis
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

7.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.

Authors:  J S Silva; G N Vespa; M A Cardoso; J C Aliberti; F Q Cunha
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.

Authors:  F Cardillo; J C Voltarelli; S G Reed; J S Silva
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease.

Authors:  W O Dutra; O A Martins-Filho; J R Cançado; J C Pinto-Dias; Z Brener; G L Freeman Júnior; D G Colley; G Gazzinelli; J C Parra
Journal:  Int Immunol       Date:  1994-04       Impact factor: 4.823

10.  Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes.

Authors:  D D Reis; E M Jones; S Tostes; E R Lopes; G Gazzinelli; D G Colley; T L McCurley
Journal:  Am J Trop Med Hyg       Date:  1993-05       Impact factor: 2.345

View more
  31 in total

Review 1.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

2.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction.

Authors:  Ludmila Rodrigues Pinto Ferreira; Frederico Moraes Ferreira; Helder Imoto Nakaya; Xutao Deng; Darlan da Silva Cândido; Lea Campos de Oliveira; Jean-Noel Billaud; Marion C Lanteri; Vagner Oliveira-Carvalho Rigaud; Mark Seielstad; Jorge Kalil; Fabio Fernandes; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Edecio Cunha-Neto
Journal:  J Infect Dis       Date:  2017-02-01       Impact factor: 5.226

4.  Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.

Authors:  Fernanda Nobre Amaral Villani; Manoel Otávio da Costa Rocha; Maria do Carmo Pereira Nunes; Lis Ribeiro do Valle Antonelli; Luisa Mourão Dias Magalhães; Janete Soares Coelho dos Santos; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

5.  Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Authors:  Kevin M Bonney; Joann M Taylor; Edward B Thorp; Conrad L Epting; David M Engman
Journal:  Parasitol Res       Date:  2015-01-11       Impact factor: 2.289

Review 6.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

Review 7.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

8.  Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.

Authors:  Suellen Carvalho de Moura Braz; Adriene Siqueira de Melo; Maria da Glória Aureliano de Melo Cavalcanti; Sílvia Marinho Martins; Wilson de Oliveira; Edimilson Domingos da Silva; Antonio Gomes Pinto Ferreira; Virginia Maria Barros de Lorena; Yara de Miranda Gomes
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

9.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Authors:  Diego C Borges; Natalia M Araújo; Cristina R Cardoso; Javier E Lazo Chica
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 10.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.